alexa Selective Modulation Of The Glucocorticoid Receptor Can Distinguish Between Transrepression Of NF- κB And AP-1
ISSN: 2161-1017

Endocrinology & Metabolic Syndrome
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Endocrinology
October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Ilse M Beck, Karolien De Bosscher, Lien Dejager, Nadia Bougarne, Anthoula Gaigneaux, S?bastien Chateauvieux, Dariusz Ratman, Marc Bracke, Jan Tavernier, Wim Vanden Berghe, Claude Libert, Marc Diederich and Guy Haegeman
ScientificTracks Abstracts: Endocrinol Metab Synd
DOI: 10.4172/2161-1017.S1.005
Abstract
Glucocorticoids (GCs) block inflammation via interference of the liganded Glucocorticoid Receptor (GR) with the activity of pro-inflammatory transcription factors NF-κB and AP-1, a mechanism known as transrepression. This mechanism is believed to involve the activity of GR monomers. Here, we explored how the GR monomer-favouring Compound A (CpdA) affects AP-1 activation and activity. Our results demonstrate that non-steroidal CpdA, unlike classic steroidal GCs, blocks NF-κBbut not AP-1-driven gene expression. CpdA rather sustains AP-1-driven gene expression, a result which could mechanistically be explained by the failure of CpdA to block upstream JNK kinase activation and concomitantly also phosphorylation of c-Jun. In concordance and in contrast to DEX, CpdA maintained the expression of the activated AP-1 target gene c-jun, as well as the production of the c-Jun protein. As for the underlying mechanism, GR is a necessary intermediate in the CpdA-mediated gene expression of AP1-regulated genes, but seems to be superfluous to CpdA-mediated JNK phosphorylation prolongation. The latter phenomenon concurs with the inability of CpdA to stimulate DUSP1 gene expression. ChIP analysis demonstrates that DEX-activated GR, but not CpdA-activated GR, is recruited to AP-1-driven promoters. Furthermore, in mice we observed that CpdA instigates a strong enhancement of TNF-induced AP-1-driven gene expression. Finally, we demonstrate that this phenomenon coincides with an increased sensitivity towards TNF lethality, and implicate again a role for JNK2. In conclusion, our data support the hypothesis that a ligand-induced differential conformation of GR yields a different transcription factor cross-talk profile. KDB, IMB, and LD are supported by FWO-Vlaanderen. DR and NB enjoy support of IWT-Vlaanderen. AG and SC S received grants from T?l?vie Luxembourg.
Biography
Ilse Beck has completed her PhD in Biotechnology at Ghent University (Belgium) in 2009, after obtaining an MSc in Biology at the age of 22 years from the Catholic University of Leuven. She performed a fellowship at the Karolinska Institute (Sweden). She continued in the Laboratory of Experimental Cancer Research at Ghent University, as a postdoctoral fellow of the Research Foundation - Flanders (FWO). She has published more than 15 papers in reputed journals. Her long-standing research focus in nuclear receptors is currently concentrated towards effects on an by nuclear receptors in solid and hematological tumors.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords